Lv2
200 积分 2025-10-22 加入
Research trends in the use of nanobodies for cancer therapy
17天前
已完结
Nanobody-based drug delivery systems for cancer therapy
17天前
已完结
Co-delivery of PDL1-blocking scFv and chemotherapeutics using engineered exosomes for cancer therapy
28天前
已完结
Characterization of Anti-CD3 Antibodies in Clinically Available Bispecific T Cell Engagers
1个月前
已完结
Novel anti-HER2 nanobody-drug conjugates with enhanced penetration of solid tumor and BBB, reduced systemic exposure and superior antitumor efficacy
1个月前
已完结
皖公网安备34019202002308
